And the interesting thing of that trial, which we reported some preliminary data, is that a large percentage of the patients are now living beyond 3 years
I wonder what Dr Brem means when he states Penn has been very active in DCVax? Is he referring to the P1 ovarian trial for L that was conducted there beginning in 2008?